TNFSF10 and diabetes mellitus: Animal and in vitro studies have reported direct biological actions of TRAIL on multiple tissues involved in diabetes pathophysiology including pancreatic islets, skeletal muscle, adipose tissue, liver, kidney, immune and vascular cells.